Literature DB >> 6795765

Protective effect of Fluosol-DA in acute cerebral ischemia.

S J Peerless, R Ishikawa, I G Hunter, M J Peerless.   

Abstract

Fluosol-DA (Perfluorochemical Blood Substitutes) are small particle fluorocarbons suspended in an emulsion and have a high propensity for carrying oxygen and carbon dioxide. Fluosol-DA was investigated for the modification of acute focal cerebral ischemia and compared to mannitol. A total of 36 adult cats were divided into 3 groups and had transorbital microtourniquet ligation of the middle cerebral artery (MCA). Control animals were given intravenous isotonic saline. Animals in the experimental groups were treated with either intravenous Fluosol-DA or mannitol. All animals were nursed in an oxygen chamber and 4 cats from each group were sacrificed at 1, 3 and 6 hours after MCA occlusion. The results of macroscopic and histological examination of the brain suggested Fluosol-DA had a definite protective effect on acute focal cerebral ischemia which was in keeping with the observed neurological outcome. It is suggested that Fluosol-DA may support flow in the microcirculation and that the small particles of Fluosol-DA may be able to reach the area of ischemia via collaterals by decreasing blood viscosity, preventing narrowing of the arteriolar and capillary lumen and increasing the cerebral blood flow.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6795765     DOI: 10.1161/01.str.12.5.558

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  12 in total

1.  Effect of bezafibrate on the sequelae of acute experimental focal cerebral ischaemia.

Authors:  B S Aspey; S Ehteshami; C M Hurst; S Pereira; M J Harrison
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-12       Impact factor: 10.154

2.  Effect of a perfluorochemical emulsion on the development of artificial lung metastases in mice.

Authors:  S Rockwell; C G Irvin; M Nierenburg
Journal:  Clin Exp Metastasis       Date:  1986 Jan-Mar       Impact factor: 5.150

3.  Artificial blood.

Authors:  P M Jones
Journal:  Br Med J (Clin Res Ed)       Date:  1983-01-22

Review 4.  Blood component therapy in anaesthetic practice.

Authors:  M A Blajchman; R Herst; R A Perrault
Journal:  Can Anaesth Soc J       Date:  1983-07

5.  Neuronal injury following permanent middle cerebral artery occlusion in cats.

Authors:  G Ebhardt; G Mies; L M Auer; H Traupe; W D Heiss
Journal:  Acta Neuropathol       Date:  1983       Impact factor: 17.088

6.  The effects of a prophylactic bolus of lidocaine in focal cerebral ischaemia.

Authors:  A W Gelb; G K Steinberg; A M Lam; P H Manninen; S J Peerless; A Rassi-Neto
Journal:  Can J Anaesth       Date:  1988-09       Impact factor: 5.063

7.  Fluosol and experimental spinal cord ischemia.

Authors:  S Kolluri; U DeGirolami; R Heros; F Vacanti; N Zervas
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

Review 8.  Current status of erythrocyte substitutes.

Authors:  G P Biro
Journal:  Can Med Assoc J       Date:  1983-08-01       Impact factor: 8.262

9.  A prophylactic bolus of thiopentone does not protect against prolonged focal cerebral ischaemia.

Authors:  A W Gelb; P Floyd; P Lok; S J Peerless; M Farrell
Journal:  Can Anaesth Soc J       Date:  1986-03

10.  The effect of isovolemic hemodilution with oxycyte, a perfluorocarbon emulsion, on cerebral blood flow in rats.

Authors:  Zhong-jin Yang; Chrystal D Price; Gerardo Bosco; Micheal Tucci; Nagwa S El-Badri; Devanand Mangar; Enrico M Camporesi
Journal:  PLoS One       Date:  2008-04-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.